Similar articles

• Blocking of guanidine action on poliovirus multiplication.

  Mosser AG, Caliguiri LA, Tamm I. Mosser AG, et al. Virology. 1971 Sep;45(3):653-63. doi: 10.1016/0042-6822(71)90179-6. Virology. 1971. PMID: 4331105 No abstract available.
• Studies on the nonneutralizable fraction of poliovirus.

  Lewenton-Kriss S, Mandel B. Lewenton-Kriss S, et al. Virology. 1972 Jun;48(3):666-78. doi: 10.1016/0042-6822(72)90151-1. Virology. 1972. PMID: 4337990 No abstract available.
• Analysis of specificity of antibodies contained in antiserum against poliovirus with mutants resistant to inhibitors in equine serum.

  Urasawa S, Urasawa T, Kanamitsu M. Urasawa S, et al. J Immunol. 1974 Aug;113(2):537-42. J Immunol. 1974. PMID: 4367633 No abstract available.
• The use of inhibitors in the study of picornavirus genetics.

  Sergiescu D, Horodniceanu F, Aubert-Combiescu A. Sergiescu D, et al. Prog Med Virol. 1972;14:123-99. Prog Med Virol. 1972. PMID: 4555915 Review. No abstract available.
• A new type 3 attenuated poliovirus for possible use in oral poliovirus vaccine.

  Vonka V, Janda Z, Simon J, Adam E, Stárek M. Vonka V, et al. Prog Med Virol. 1967;9:204-55. Prog Med Virol. 1967. PMID: 4293687 Review. No abstract available.